BiomX IncPHGE
Price$1.85

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $332K0.0% YoYTTM through 31 Dec 2025
Net Income -$36.2MTTM through 31 Dec 2025
Free Cash Flow -$26.5MTTM through 31 Dec 2025

Margins

Current
Gross Margin0.0%
Operating Margin-12,489.8%
Net Margin-10,903.3%

Balance Sheet Health

Debt / Equity0.00x
Current Ratio0.87x
Net Debt-$3.6Mnet cash position
Cash & Equivalents$5M

Quality Metrics

FCF Margin-7,978.9%
Earnings-Beat Rate50.0%

Dividend

No dividend

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.